CYP1B1-AS1
gene geneOn this page
Also known as MGC34824
Summary
CYP1B1-AS1 (CYP1B1 antisense RNA 1, HGNC:28543) is a long non-coding RNA gene on chromosome 2p22.2.
Predicted to enable U4 snRNA binding activity. Predicted to be involved in formation of quadruple SL/U4/U5/U6 snRNP and spliceosomal tri-snRNP complex assembly. Predicted to be part of U4/U6 x U5 tri-snRNP complex and U6 snRNP.
Source: NCBI Gene 285154 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28543 |
| Approved symbol | CYP1B1-AS1 |
| Name | CYP1B1 antisense RNA 1 |
| Location | 2p22.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | MGC34824 |
| Ensembl gene | ENSG00000232973 |
| Ensembl biotype | lncRNA |
| Entrez | 285154 |
| RNAcentral | URS000075B013 — lncRNA, 1776 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 78 — 78 lncRNA
ENST00000413828, ENST00000427168, ENST00000585654, ENST00000589303, ENST00000593090, ENST00000603809, ENST00000606100, ENST00000606849, ENST00000609128, ENST00000609565, ENST00000610024, ENST00000610172, ENST00000612373, ENST00000620177, ENST00000625348, ENST00000626166, ENST00000626456, ENST00000626582, ENST00000626718, ENST00000626865, ENST00000627172, ENST00000627992, ENST00000628097, ENST00000628135, ENST00000628165, ENST00000628232, ENST00000628238, ENST00000628580, ENST00000629439, ENST00000629547, ENST00000629719, ENST00000629773, ENST00000630542, ENST00000630623, ENST00000630658, ENST00000653077, ENST00000653994, ENST00000657397, ENST00000660098, ENST00000660493, ENST00000767219, ENST00000767220, ENST00000767221, ENST00000767222, ENST00000767223, ENST00000767224, ENST00000767225, ENST00000767226, ENST00000767227, ENST00000767228, ENST00000767229, ENST00000767230, ENST00000767231, ENST00000767232, ENST00000767233, ENST00000767234, ENST00000767235, ENST00000767236, ENST00000767237, ENST00000767238, ENST00000767239, ENST00000767240, ENST00000767241, ENST00000767242, ENST00000767243, ENST00000767244, ENST00000767245, ENST00000767246, ENST00000767247, ENST00000767248, ENST00000767249, ENST00000767250, ENST00000767251, ENST00000767252, ENST00000767253, ENST00000767254, ENST00000767255, ENST00000767256
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000413828 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001671350 | 38131511 | 38131614 |
| ENSE00001706852 | 38131089 | 38131190 |
| ENSE00001768388 | 38180289 | 38181855 |
| ENSE00003765177 | 38108073 | 38108080 |
Expression profiles
Bgee: expression breadth ubiquitous, 161 present calls, max score 91.65.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2576 / max 39.9712, expressed in 442 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 19820 | 0.7256 | 274 |
| 19824 | 0.2790 | 134 |
| 19819 | 0.2531 | 116 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 91.65 | gold quality |
| tibial nerve | UBERON:0001323 | 87.47 | gold quality |
| colonic epithelium | UBERON:0000397 | 84.91 | gold quality |
| monocyte | CL:0000576 | 84.61 | gold quality |
| leukocyte | CL:0000738 | 84.05 | gold quality |
| calcaneal tendon | UBERON:0003701 | 82.30 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.87 | gold quality |
| left uterine tube | UBERON:0001303 | 81.34 | gold quality |
| body of uterus | UBERON:0009853 | 80.68 | gold quality |
| omental fat pad | UBERON:0010414 | 76.70 | gold quality |
| peritoneum | UBERON:0002358 | 76.61 | gold quality |
| endocervix | UBERON:0000458 | 76.35 | gold quality |
| bone marrow cell | CL:0002092 | 76.14 | gold quality |
| apex of heart | UBERON:0002098 | 75.46 | gold quality |
| right uterine tube | UBERON:0001302 | 75.15 | gold quality |
| adrenal tissue | UBERON:0018303 | 75.14 | gold quality |
| ectocervix | UBERON:0012249 | 74.91 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 74.86 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.76 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 74.74 | gold quality |
| uterine cervix | UBERON:0000002 | 73.96 | gold quality |
| right atrium auricular region | UBERON:0006631 | 73.73 | gold quality |
| granulocyte | CL:0000094 | 73.37 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 73.33 | gold quality |
| skin of leg | UBERON:0001511 | 73.12 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.09 | gold quality |
| cardiac atrium | UBERON:0002081 | 72.88 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 72.72 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 72.38 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 72.36 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9543 | yes | 9.89 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Functional variant rs10175368 which affects the expression of CYP1B1 plays a protective role against breast cancer in a Chinese Han population. (PMID:37038992)
- FOXO1-regulated lncRNA CYP1B1-AS1 suppresses breast cancer cell proliferation by inhibiting neddylation. (PMID:37640964)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.